Skip to content

Comparison of analgesic effect of intravenous paracetamol and fentanyl during colonoscopy

Comparison of analgesic effect of intravenous paracetamol and fentanyl during colonoscopy: Prospective double blind clinical trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT201311227752N5
Enrollment
60
Registered
2013-12-10
Start date
2013-08-22
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Pain. Acute pain

Interventions

Intervention 1: The intervention group receives 1gr intravenous Paracetamol in 100 cc normal saline for 30 min before colonoscopy. Intervention 2: Control group receives fentanyl and 100 ml DW5%30 mi
Treatment - Drugs
The intervention group receives 1gr intravenous Paracetamol in 100 cc normal saline for 30 min before colonoscopy
Control group receives fentanyl and 100 ml DW5%30 minutes before colonoscopy.

Sponsors

Vice-chancellor of research of Babol University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 70 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: age 20-70 years; ASA class = 3 Exclusion criteria: age 70 years; Heart disease (arrhythmias, Aortic Stenosis, Ischemic Heart Disease,Heart failure) ; liver disease (Child-Pugh classification C);kidney disease ; lack of patient cooperation;mental illness (major Depression, mania, psychosis); Hypotension;Hypertension; drug addiction.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Pain. Timepoint: 12 hours after colonoscopy. Method of measurement: Visoal analoge Scale.

Secondary

MeasureTime frame
Sedation. Timepoint: 12 hours after clonoscopy. Method of measurement: Ramsay Sedation Scale.;Nause and vomiting. Timepoint: 12 hours after clonoscopy. Method of measurement: yes/no.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactAmrimaleh, Parviz

Babol University of Medical Sciences

pamrimaleh@yahoo.com+98 11 1223 8296

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026